What is he best known for?
The fields of study he is best known for:
- Gene
- DNA
- Internal medicine
His primary areas of investigation include Genetic enhancement, Virology, Stem cell, Viral vector and Haematopoiesis.
His Genetic enhancement research is multidisciplinary, incorporating elements of Vector, Factor IX, CD34, Molecular biology and Leukemia.
His Molecular biology research is multidisciplinary, incorporating perspectives in Complementary DNA and Gene.
His work in Stem cell addresses subjects such as Bone marrow, which are connected to disciplines such as Genetic transfer and Cancer research.
His studies in Viral vector integrate themes in fields like Vesicular stomatitis virus and Transplantation.
His study looks at the relationship between Haematopoiesis and topics such as Simian immunodeficiency virus, which overlap with Hematopoietic stem cell, Murine leukemia virus and Genome.
His most cited work include:
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B (1262 citations)
- Long-term safety and efficacy of factor IX gene therapy in hemophilia B (719 citations)
- Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. (688 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Molecular biology, Genetic enhancement, Viral vector, Gene and Haematopoiesis.
His Molecular biology study integrates concerns from other disciplines, such as Promoter, Gene expression, Locus control region, Green fluorescent protein and Globin.
His Genetic enhancement research incorporates elements of Virology, Vector, Factor IX, Immunology and CD34.
His Viral vector research includes elements of Insertional mutagenesis, Genetic transfer, Transfection, Transduction and Hematopoietic stem cell.
Arthur W. Nienhuis works mostly in the field of Haematopoiesis, limiting it down to topics relating to Bone marrow and, in certain cases, Lymphocyte and Myeloid, as a part of the same area of interest.
His study in Stem cell is interdisciplinary in nature, drawing from both Cancer research and Transplantation.
He most often published in these fields:
- Molecular biology (41.33%)
- Genetic enhancement (36.22%)
- Viral vector (31.63%)
What were the highlights of his more recent work (between 2009-2020)?
- Viral vector (31.63%)
- Genetic enhancement (36.22%)
- Molecular biology (41.33%)
In recent papers he was focusing on the following fields of study:
Viral vector, Genetic enhancement, Molecular biology, Immunology and Factor IX are his primary areas of study.
His research integrates issues of Genome, CD34, Restriction enzyme and Transplantation in his study of Viral vector.
He interconnects Haematopoiesis, Cancer research, Vector, B cell and Wiskott–Aldrich syndrome in the investigation of issues within Genetic enhancement.
The Molecular biology study combines topics in areas such as Virology, Globin, Gene, Green fluorescent protein and Promoter.
His Immunology research incorporates themes from Thalassemia, Beta thalassemia, Endocrinology and Red Cell.
His Factor IX study combines topics in areas such as Virus, Immunosuppression, Clinical trial and Transgene.
Between 2009 and 2020, his most popular works were:
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B (1262 citations)
- Long-term safety and efficacy of factor IX gene therapy in hemophilia B (719 citations)
- Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins. (215 citations)
In his most recent research, the most cited papers focused on:
- Gene
- DNA
- Internal medicine
Arthur W. Nienhuis spends much of his time researching Immunology, Genetic enhancement, Molecular biology, Virus and Factor IX.
Arthur W. Nienhuis combines subjects such as Thalassemia, Internal medicine and Fetal hemoglobin with his study of Immunology.
His Genetic enhancement study incorporates themes from Vector and Immune system.
His Molecular biology research is multidisciplinary, relying on both Viral vector and Polymerase chain reaction.
His Factor IX research is multidisciplinary, incorporating perspectives in Clinical trial, Transgene and Ion chromatography.
Asymptomatic is closely connected to Gastroenterology in his research, which is encompassed under the umbrella topic of Transgene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
